Logo S12 500 (Synjardy empagliflozin 12.5 mg / metformin hydrochloride 500 mg)
Generic Name: empagliflozin/metformin
Pill imprint Logo S12 500 has been identified as Synjardy empagliflozin 12.5 mg / metformin hydrochloride 500 mg.
Synjardy is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Synjardy empagliflozin 12.5 mg / metformin hydrochloride 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo S12 500
- empagliflozin 12.5 mg / metformin hydrochloride 500 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
More about Synjardy (empagliflozin / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.